array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(13) "Pharming B.V."
["slug"]=>
string(20) "00474-nl-pharming-bv"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/6f06b060-b806-43f2-addd-a605083bf776"
["description"]=>
string(987) "Pharming is a global biopharmaceutical company that develops and commercializes innovative protein replacement therapies and precision medicines for rare diseases. They are committed to being a sustainable partner for all stakeholder groups, including patients, healthcare professionals, employees, and shareholders. Pharming is headquartered in Leiden, the Netherlands, with its U.S. headquarters in Warren, New Jersey. They are listed on the Amsterdam Euronext and Nasdaq exchanges. Their vision is to become the leading global rare disease company and their mission is to bring solutions to unserved rare disease patients through drug development and commercialization. They aim to transform their pipeline to include multiple commercialized products in multiple geographies and to expand their technology portfolio. The company culture at Pharming emphasizes teamwork, self-development, and results orientation. They participate in investor conferences and provide financial updates."
["address_street"]=>
string(12) "Darwinweg 24"
["address_place"]=>
string(6) "Leiden"
["address_region"]=>
NULL
["founding_date"]=>
NULL
["website_domain"]=>
string(12) "pharming.com"
["website_url"]=>
string(24) "https://www.pharming.com"
["industry_codes"]=>
array(1) {
[0]=>
string(75) "Industrial and Commercial Machinery and Equipment, Not Elsewhere Classified"
}
["employee_count"]=>
NULL
["article_count"]=>
int(54)
}
["articles"]=>
array(4) {
[0]=>
array(7) {
["title_en"]=>
string(110) "Leiden company Pharming can get back to money after US government intervention in bankrupt Silicon Valley Bank"
["snippet_en"]=>
string(229) "The US government will give account holders at the collapsed Silicon Valley Bank (SVB) access to all their assets from Monday. This also applies to the Leiden biotech company Pharming, which had deposited tens of millions at SVB."
["url"]=>
string(144) "https://www.bd.nl/economie/leids-bedrijf-pharming-kan-weer-bij-geld-na-ingrijpen-amerikaanse-overheid-op-failliet-sillicon-valley-bank~ada15766/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/e37a93be-07e9-4534-8eda-6eb41a40ff2c"
["source"]=>
string(5) "bd.nl"
["publication_date"]=>
string(10) "2023-03-13"
["categories"]=>
array(2) {
[0]=>
string(10) "Insolvency"
[1]=>
string(24) "Government Interventions"
}
}
[1]=>
array(7) {
["title_en"]=>
string(76) "Pharming does not expect any damage from the collapse of Silicon Valley Bank"
["snippet_en"]=>
string(135) "The actions of the US and UK governments and central banks to limit the damage around the bankrupt Silicon Valley Bank (SVB) lead to…"
["url"]=>
string(107) "https://fd.nl/bedrijfsleven/3693272/1470359/pharming-verwacht-geen-schade-door-omvallen-silicon-valley-bank"
["image_url"]=>
NULL
["source"]=>
string(5) "fd.nl"
["publication_date"]=>
string(10) "2023-03-13"
["categories"]=>
array(1) {
[0]=>
string(10) "Insolvency"
}
}
[2]=>
array(7) {
["title_en"]=>
string(71) "Biotech company Pharming owes $45 million to failed Silicon Valley Bank"
["snippet_en"]=>
string(126) "The Dutch biotech company Pharming could be hit hard by a possible bankruptcy of the Silicon Valley Bank (SVB). Farming has..."
["url"]=>
string(124) "https://fd.nl/bedrijfsleven/3693272/1470318/biotechbedrijf-pharming-heeft-45-mln-bij-omgevallen-silicon-valley-bank-uitstaan"
["image_url"]=>
NULL
["source"]=>
string(5) "fd.nl"
["publication_date"]=>
string(10) "2023-03-12"
["categories"]=>
array(1) {
[0]=>
string(10) "Insolvency"
}
}
[3]=>
array(7) {
["title_en"]=>
string(61) "Pharming has millions in bankrupt Silicon Valley Bank account"
["snippet_en"]=>
string(148) "LEAD (ANP) - Biotech company Pharming has a total of $ 45 million in an account with the collapsed Silicon Valley Bank. That's about a quarter of it"
["url"]=>
string(99) "https://www.zeelandnet.nl/nieuws/pharming-heeft-miljoenen-op-rekening-failliete-silicon-valley-bank"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/4997a50f-a277-46fe-86cd-1ca0ef0f1863"
["source"]=>
string(13) "zeelandnet.nl"
["publication_date"]=>
NULL
["categories"]=>
array(1) {
[0]=>
string(10) "Insolvency"
}
}
}
["category_annotations"]=>
array(28) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(12)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(8)
}
[2]=>
array(2) {
["name"]=>
string(10) "Insolvency"
["count"]=>
int(4)
}
[3]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(4)
}
[4]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(3)
}
[5]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(3)
}
[6]=>
array(2) {
["name"]=>
string(9) "Investors"
["count"]=>
int(2)
}
[7]=>
array(2) {
["name"]=>
string(21) "Financial Performance"
["count"]=>
int(2)
}
[8]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(2)
}
[9]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(1)
}
[10]=>
array(2) {
["name"]=>
string(10) "Executives"
["count"]=>
int(1)
}
[11]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(1)
}
[12]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(1)
}
[13]=>
array(2) {
["name"]=>
string(24) "Government Interventions"
["count"]=>
int(1)
}
[14]=>
array(2) {
["name"]=>
string(14) "Product Review"
["count"]=>
int(1)
}
[15]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(1)
}
[16]=>
array(2) {
["name"]=>
string(21) "Shareholders Feedback"
["count"]=>
int(1)
}
[17]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(1)
}
[18]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(1)
}
[19]=>
array(2) {
["name"]=>
string(9) "Valuation"
["count"]=>
int(1)
}
[20]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(1)
}
[21]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(1)
}
[22]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(1)
}
[23]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(1)
}
[24]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(1)
}
[25]=>
array(2) {
["name"]=>
string(5) "Debts"
["count"]=>
int(1)
}
[26]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(1)
}
[27]=>
array(2) {
["name"]=>
string(7) "Economy"
["count"]=>
int(1)
}
}
}
00474-nl-pharming-bv
Pharming B.V.
Location
Founded
Website
https://www.pharming.com
Articles
54 Articles
Category
Industrial and Commercial Machinery and Equipment, Not Elsewhere Classified
Description
Pharming is a global biopharmaceutical company that develops and commercializes innovative protein replacement therapies and precision medicines for rare diseases. They are committed to being a sustainable partner for all stakeholder groups, including patients, healthcare professionals, employees, and shareholders. Pharming is headquartered in Leiden, the Netherlands, with its U.S. headquarters in Warren, New Jersey. They are listed on the Amsterdam Euronext and Nasdaq exchanges. Their vision is to become the leading global rare disease company and their mission is to bring solutions to unserved rare disease patients through drug development and commercialization. They aim to transform their pipeline to include multiple commercialized products in multiple geographies and to expand their technology portfolio. The company culture at Pharming emphasizes teamwork, self-development, and results orientation. They participate in investor conferences and provide financial updates.
The US government will give account holders at the collapsed Silicon Valley Bank (SVB) access to all their assets from Monday. This also applies to the Leiden biotech company Pharming, which had deposited tens of millions at SVB.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
